State Street Corp Vyant Bio, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.62 - $1.37 $1,984 - $4,384
3,200 Added 4.44%
75,200 $68,000
Q1 2022

May 16, 2022
BUY
$0.99 - $1.61 $6,265 - $10,189
6,329 Added 9.64%
72,000 $103,000
Q3 2021

Nov 15, 2021
BUY
$2.26 - $3.74 $29,153 - $48,246
12,900 Added 24.45%
65,671 $153,000
Q2 2021

Aug 16, 2021
BUY
$2.88 - $4.81 $151,980 - $253,828
52,771 New
52,771 $197,000

Others Institutions Holding VYNT

# of Institutions
2
Shares Held
213K
Call Options Held
0
Put Options Held
0
View Full List

About Vyant Bio, Inc.

VYNT Quotes by TradingView
  • Ticker VYNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,343,200
  • Description
  • Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...
More about VYNT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email